A PHASE 3, MULTI-SITE, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ERAPA TO IMPROVE CLINICAL OUTCOMES IN PARTICIPANTS WITH FAMILIAL ADENOMATOUS POLYPOSIS
- Registry ID
- MTX230-301
- Source registry
- HEALTH_CANADA
- Status
- Pending
- Phase
- PHASE3
- Study type
- INTERVENTIONAL
- Sponsor
- EMTORA BIOSCIENCES
- Last update
- 2026-06-23
Conditions
- FAMILIAL ADENOMATOUS POLYPOSIS
View on source registry